Zhang Tian-Guang, Miao Chao-Yu
Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
Acta Pharm Sin B. 2023 Mar;13(3):1028-1035. doi: 10.1016/j.apsb.2022.10.008. Epub 2022 Oct 11.
Mitochondrial diseases are a group of inherited or acquired metabolic disorders caused by mitochondrial dysfunction which may affect almost all the organs in the body and present at any age. However, no satisfactory therapeutic strategies have been available for mitochondrial diseases so far. Mitochondrial transplantation is a burgeoning approach for treatment of mitochondrial diseases by recovery of dysfunctional mitochondria in defective cells using isolated functional mitochondria. Many models of mitochondrial transplantation in cells, animals, and patients have proved effective various routes of mitochondrial delivery. This review presents different techniques used in mitochondrial isolation and delivery, mechanisms of mitochondrial internalization and consequences of mitochondrial transplantation, along with challenges for clinical application. Despite some unknowns and challenges, mitochondrial transplantation would provide an innovative approach for mitochondrial medicine.
线粒体疾病是一组由线粒体功能障碍引起的遗传性或获得性代谢紊乱疾病,几乎可影响身体的所有器官,可在任何年龄发病。然而,迄今为止,线粒体疾病尚无令人满意的治疗策略。线粒体移植是一种新兴的治疗线粒体疾病的方法,即利用分离出的功能正常的线粒体恢复缺陷细胞中功能失调的线粒体。细胞、动物和患者的许多线粒体移植模型已证明,通过各种线粒体递送途径均有效。本文综述了线粒体分离和递送中使用的不同技术、线粒体内化机制和线粒体移植的后果,以及临床应用面临的挑战。尽管存在一些未知因素和挑战,但线粒体移植将为线粒体医学提供一种创新方法。